AdvaMed: Looming Price Caps In India Detrimental To Patient Access
This article was originally published in PharmAsia News
Executive Summary
Global device makers operating in India are opposing several government recommendations that include capping prices of medical devices and a preferential procurement system for indigenously made devices. The moves, if finalized, will be detrimental to ensuring access to patients, lobby groups are warning.